On 22 March, the Cybersecurity Administration of China (CAC) released the final version of a regulation governing the overseas transfer of personal, business and other data, including of health and medical data with implications for the biopharma industry.
China Implements Data Transfer Regulation, With Some Waivers
Sensitive Data Transfers Tightened
A newly enacted regulation in China governing the overseas transfer of data allows waivers under certain conditions but also introduces some new hurdles compared to the draft version.
